Showing 30 of 3783 posts
Hikma delivers solid growth, a chunky $250m buyback, and a leadership shake-up. Dividend lifted 5% to reward shareholders.
JoshuaFebruary 26, 2026
Drax's 2025 results: record renewable generation, strategic CfD boosting earnings stability, and robust cash flows for shareholders.
JoshuaFebruary 26, 2026
Seplat Energy's 2025 results show a 144% revenue surge and a 52% dividend hike, driven by a major operational step-change and powerful cash flow growth.
JoshuaFebruary 26, 2026
Electrica's record 2025 profits & EBITDA surge, driven by supply rebound after price cap removal and strong distribution performance.
JoshuaFebruary 26, 2026
Corcel PLC delivers milestone 326 line-km seismic acquisition in Angola, paving a clear path to high-impact drilling in the Kwanza Basin.
JoshuaFebruary 26, 2026
Contango plans a £5m premium equity raise to become debt-free, backed by US$2m annual royalties from the Muchesu project.
JoshuaFebruary 26, 2026
Pantheon International's half-year shows a 4.9% NAV rise, a narrowing discount from 40% to 28%, and strategic shifts like fee cuts and buybacks.
JoshuaFebruary 26, 2026
CK Infrastructure and Engie-led consortium to buy UK Power Networks Holdings in 100% acquisition, pending regulatory approvals for mid-2026 completion.
JoshuaFebruary 26, 2026
Record profits and a strong dividend: BBK posts an 11.1% rise in net profit to BD 80.0m for 2025, alongside a proposed 40 fils per share payout.
JoshuaFebruary 25, 2026
Insight: Electrica's 500 MW solar-storage MoU with Liberty Galati in Romania aims for cost savings via self-consumption. Details pending.
JoshuaFebruary 25, 2026
Discover Fairview International PLC's H1 2025 growth: 7% revenue and 13% gross profit rise, driven by operating leverage and strategic initiatives.
JoshuaFebruary 25, 2026
Avingtrans reports improved profits, stronger cash flow and a higher dividend, backed by robust nuclear demand and FDA clearance for its Adaptix medical imaging system.
JoshuaFebruary 25, 2026
Home REIT's 2025 report reveals deeper losses and lower NAV as wind-down advances, but SFO probe and litigation risk delay capital returns.
JoshuaFebruary 25, 2026
Golden Rock Global cancels convertible loan notes to remove dilution risk, replacing them with a zero-interest repayment loan due upon re-admission after its reverse takeover.
JoshuaFebruary 25, 2026
Jet2's FY26 profit guidance hits £439m target ahead of Gatwick base launch, with capacity growth and cost efficiency driving strategic expansion.
JoshuaFebruary 25, 2026
Platform Housing Group's Q3 2025 update shows solid delivery but margin pressures, leading S&P to revise its credit outlook to negative.
JoshuaFebruary 25, 2026
Star Energy's 2025 trading update reveals major cost savings & cash discipline, driving share price from 7.4p to 13.5p. Key operational fixes underway.
JoshuaFebruary 25, 2026
St. James’s Place accelerates shareholder returns to 70% and posts record FUM of £220bn, signalling confidence in strong cash generation.
JoshuaFebruary 25, 2026
Humming West End: Shaftesbury Capital's 2025 growth with rising income, values, dividends & NBIM's Covent Garden stake.
JoshuaFebruary 25, 2026
AFC Energy's FY25 reset focuses on LC30 & Hy-5 product sales, targeting 2026 as the pivot year from R&D to revenue.
JoshuaFebruary 25, 2026
Hiscox announces record 2025 profits with a 20% dividend hike and $300m share buyback, alongside its best underwriting margin in a decade.
JoshuaFebruary 25, 2026
Glanbia's 2025: revenue climbs but margins tight; strategic shift and €100m buyback signal confidence.
JoshuaFebruary 25, 2026
Record FY 2025 results: profits jump 35%, dividend hiked 20%, backed by a record £19.1bn pipeline and a rock-solid cash-rich balance sheet.
JoshuaFebruary 25, 2026
Hammerson reports robust FY25 results with 23% net rental income growth, rising earnings and dividends, plus positive guidance for further growth in FY26.
JoshuaFebruary 25, 2026
Diageo cuts dividend amid US & China weakness but maintains cash flow and strategic balance sheet focus-key takeaways from interim results.
JoshuaFebruary 25, 2026
Roadside Real Estate completes acquisition of Gardner Retail, de-risking the deal. Attention now turns to integration and delivery.
JoshuaFebruary 25, 2026
GSK bets $950M on 35Pharma's HS235 for pulmonary hypertension, a drug with reduced bleeding risk and metabolic perks.
JoshuaFebruary 25, 2026
Haleon proposes 7.1p dividend for 2025 from strong cash flow, with a disciplined 38% payout ratio signalling confidence.
JoshuaFebruary 25, 2026
Discover how Norman Broadbent's acquisition of Society Limited punches above its weight in third sector and Travel & Hospitality markets.
JoshuaFebruary 25, 2026
AdvancedAdvT beats FY26 forecasts with over 27% EBITDA margins and 80% recurring revenue. Steady execution delivers growth and optionality.
JoshuaFebruary 25, 2026